Day One: Friday, November 6, 2020

All times in Eastern Time

Welcome to IKCS 202010:00 a.m.
Andrew C. Novick Memorial Lecture
Partial Nephrectomy: An Ongoing Journey for Surgical Excellence
10:15 a.m.Steven Campbell, MD, PhD
Multimodality Therapy for Locally Advanced RCCModerators:
Deborah Kaye, MD, MS
Stephanie Berg, DO
Discussion of Multimodality Therapy10:55 a.m. Panelists:
Libby Wulff-Birchfield, MD
Ivan Pedrosa, MD, PhD,
and Rahul Sheth, MD
Target Populations For Adjuvant/Perioperative Trials11:15 a.m. Naomi Haas, MD
Imaging Endpoints (RECIST vs. irRECIST)11:25 a.m.Raj Gupta, MD
Perioperative Trial Design Round Table11:35 a.m.Panelists:
Mohamad Allaf, MD
Paul Russo, MD
Naomi Haas, MD
Raj Gupta, MD
Break12:00 p.m.
Lunch Satellite Symposium Session: Non-CME
Sponsored by Pfizer Oncology

A Combination First-Line Treatment Option for
Advanced Renal Cell Carcinoma (RCC)
12:00 p.m. Amit Mehta, MD
Non-Clear Cell RCCModerators:
Marie Carlo, MD
Adam Metwalli, MD
Non-Clear Cell Trial Design Round Table1:15 p.m. Panelists:
Brad McGregor, MD
Darren Feldman, MD
Hyung Kim, MD
Brian Shuch, MD
Discussion of Novel Approaches in Non-Clear Cell1:45 p.m.Panelists:
Mark Ball, MD
Aikseng Ooi, PhD
Jack Gleeson, MD
Matthew T. Campbell, MD, MS
Immunotherapy and Emerging Therapies for RCCModerators:
Katy Beckerman, MD, PhD
Eric Kauffman, MD
TKI/IO On Tumor Microenvironment 2:10 p.m.Charles Drake, MD, PhD
Biomarkers For Immunotherapy2:30 p.m. Tim Chan, MD, PhD
PARP Inhibitors for RCC2:45 p.m.Vladimir Kolenko, MD, PhD
Q+A3:00 p.m.
Discussion of Novel Approaches to Immunotherapy3:15 p.m.Panelists:
Alex Chehrazi-Raffle, MD
Johanna Bendell, MD
Nizar J. Tannir, MD
Matthew D. Tucker, MD
Break–Visit the Virtual Exhibits3:40 p.m.
Metabolism as a Target for RCCModerators:
Tracy Rose, MD, MPH
Gopal Gupta, MD
Metabolism As A Driver For RCC Discussion4:00 p.m.Panelists:
Ed Resnik, PhD
Laura Banaszynski, PhD
Nizar Tannir, MD
Shuchi Gulati, MD
Adjournment4:25 p.m.
Virtual Poster Walks4:45 p.m.
Virtual Networking and KOL Chats4:30 p.m.
to 6:00 p.m.

Day Two: Saturday, November 7, 2020

All times in Eastern Time

Breakfast Satellite Symposium Session: Non-CME
Sponsored by Exelixis

CABOMETYX®: Treatment for Patients With
Advanced Renal Cell Carcinoma
7:00 a.m.Daniel George, MD
Welcome to Day Two8:00 a.m.
Multimodality Therapy for Metastatic RCCModerators:
Rana McKay, MD
Jason Abel, MD
Perioperative Treatment Strategies in Renal Cell Carcinoma8:05 a.m. Axel Bex, MD, PhD
IO/IO as First Line Therapy8:35 a.m. Ulka Vaishampayan, MD
TKI/IO as First Line Therapy8:50 a.m.Suzanne Cole, MD
Discussion of First Line Therapy Q+A9:05 a.m.
International Considerations Panel9:25 a.m. Panelists:
Laurence Albiges, MD, PhD, France
Guillermo de Velasco, MD, PhD, Spain
Andre Faye, MD, Brazil
Viktor Grunwald, MD, PhD, Germany
Masatoshi Eto, MD, Japan
International Considerations Q+A9:55 a.m.
Break–Visit the Virtual Exhibits10:10 a.m.
Keynote Lecture and Q+A
New Therapies for Kidney Cancer Based on Studies of the VHL Tumor Suppressor Gene
10:30 a.m.William G. Kaelin, Jr., MD
Dana-Farber Cancer Institute
Top AbstractsModerators:
Abhishek Tripathi, MD
Arpita Desai, MD
Funding Mechanisms for RCC: Foundations and Government11:20 a.m.Eric Jonasch, MD
Kidney Cancer Association Young Investigator Award Recipient11:30 a.m.Pavlos Msaouel, MD, PhD
Introduction to the DOD Mentorship program11:40 a.m.Brian Rini, MD
DOD Mentee Five-Minute Presentations11:45 a.m.Presenters:
Abhishek Chakraborty, PhD
Lucas A. Salas, MD, MSc, MPH, PhD
David Braun, MD, PhD
Q+A12:00 p.m.
Rapid Fire Top Abstracts Discussion12:15 p.m.Brian Rini, MD
Eric Jonasch, MD
Alex Chehrazi-Raffle, MD
Luis Meza, MD
Sumanta Pal, MD
Yue Zhao, MBBS, MSc, PhD
Break–Visit the Virtual Exhibits12:30 p.m.
Lunch by the WoodFire1:00 p.m.Moderator:
Christopher G. Wood, MD, FACS

Tian Zhang, MD
Vitaly Margulis, MD
Sarah Psutka, MD, MSc
Thomas E. Hutson, DO, PharmD, FACP
Closing Comments1:40 p.m.
IKCS/Virtual Patient Symposium Joint Session
Treating Kidney Cancer in a Pandemic: Lessons from COVID-19
Matt Campbell, MD, MS
William C. Huang, MD
Discussion of Treating Kidney Cancer in a Pandemic1:45 p.m. to
2:15 p.m.
Brian Shinder, MD
Martin H. Voss, MD
Megan Conley, patient
Arnav Srivastava, MD

Accreditation is jointly provided by The France Foundation and the Kidney Cancer Association.

The France Foundation designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For more CME information visit: